188 related articles for article (PubMed ID: 30308184)
1. Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator.
Jahanafrooz Z; Motamed N; Rinner B; Mokhtarzadeh A; Baradaran B
Life Sci; 2018 Nov; 213():236-247. PubMed ID: 30308184
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
3. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance.
Tuli HS; Mittal S; Aggarwal D; Parashar G; Parashar NC; Upadhyay SK; Barwal TS; Jain A; Kaur G; Savla R; Sak K; Kumar M; Varol M; Iqubal A; Sharma AK
Semin Cancer Biol; 2021 Aug; 73():196-218. PubMed ID: 33130037
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibited autophagy and mitochondrial apoptosis in pancreatic carcinoma by activating JNK/SAPK signaling.
Zhang X; Jiang J; Chen Z; Cao M
Pathol Res Pract; 2019 Sep; 215(9):152530. PubMed ID: 31351801
[TBL] [Abstract][Full Text] [Related]
5. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
6. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2011 Oct; 16(10):1042-53. PubMed ID: 21779837
[TBL] [Abstract][Full Text] [Related]
7. Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b/miR-182 in human breast cancer cells.
Hossainzadeh S; Ranji N; Naderi Sohi A; Najafi F
J Cell Physiol; 2019 Dec; 234(12):22285-22298. PubMed ID: 31073992
[TBL] [Abstract][Full Text] [Related]
8. Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells.
Ge Y; Zhang Y; Chen Y; Li Q; Chen J; Dong Y; Shi W
Int J Mol Sci; 2011; 12(8):4861-71. PubMed ID: 21954330
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of Silibinin Effects on Cell Cycling and Apoptosis in Human Breast Cancer MCF-7 and T47D Cell Lines.
Jahanafrooz Z; Motameh N; Bakhshandeh B
Asian Pac J Cancer Prev; 2016; 17(5):2661-5. PubMed ID: 27268647
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells.
Zhang Y; Ge Y; Chen Y; Li Q; Chen J; Dong Y; Shi W
Cell Biochem Funct; 2012 Apr; 30(3):243-8. PubMed ID: 22170400
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of urinary bladder cancer cell proliferation by silibinin.
Barros TMB; Lima APB; Almeida TC; da Silva GN
Environ Mol Mutagen; 2020 Apr; 61(4):445-455. PubMed ID: 32078183
[TBL] [Abstract][Full Text] [Related]
12. Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells.
Zhang Y; Li Q; Ge Y; Chen Y; Chen J; Dong Y; Shi W
Phytother Res; 2013 Mar; 27(3):397-403. PubMed ID: 22619007
[TBL] [Abstract][Full Text] [Related]
13. Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.
Sameri S; Mohammadi C; Mehrabani M; Najafi R
BMC Complement Med Ther; 2021 May; 21(1):160. PubMed ID: 34059044
[TBL] [Abstract][Full Text] [Related]
14. Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines.
Zhang Y; Ge Y; Ping X; Yu M; Lou D; Shi W
Mol Med Rep; 2018 Aug; 18(2):1835-1841. PubMed ID: 29901126
[TBL] [Abstract][Full Text] [Related]
15. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
[TBL] [Abstract][Full Text] [Related]
16. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
18. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
20. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
